MAP Trainer Webinar October 14, 2015

 What's New?  Trends  Updates  Reminders  Best Practice Agenda

Available soon Revision 2015

 FAQ’s  General public  Service Providers  High Alert Medications What’s New

 MAP Resource

What’s New 2  High Alert Medication  Suboxone® ( Buprenorphine/naloxone)  Informational webinar  MAP Specific PowerPoint

 Cannabidiol (CBD) Treatment Study for  Drug Resistant Epilepsy  Directed by  Dr. Thiele from MGH What’s New 3

 Administration only by  Family  Nursing  Storage  Documentation Cannabidiol Treatment Study

Sample Med Sheet

 Medication Security  Restricted access  Medication keys  Two sets  One in use  Second set accessed through  Administrative staff Trends

 Leave of Absence  Documentation  Medication sheet  LOA code  Med progress note  Indicating where the person is  Unless included on  LOA form  Two signatures  Staff Releasing  Family Accepting Trends Continued

 Disposal Records  Top Heading  Agency  Program Site  DPH Registration Number  Bottom  Numbering each page Trends 3

 Organizational Chart Update #1

 Clozapine  Medication sheet  Must include  Date of next lab draw Update #2

Revised DPH MOR Form

Reminder  Medication Occurrence  Reporting Timeline  Within 7 days  MAP Coordinator  24 hours, if ‘Hotline’  DPH Clinical Reviewer  MAP Coordinator

.

Medication Occurrence Reports  MOR Binder includes both  Original MORs  Corresponding  Training record  Staff Attendance  Content covered

 Protocols  Signed by HCP  Posted/Verified  Monthly Medication Sheet  Quality check  Date Best Practice

Next Webinar Date